Avalo Therapeutics AVTX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avalo Therapeutics's prepaid & other current?
- Avalo Therapeutics (AVTX) reported prepaid & other current of $6.69M in Q1 2026.
- How has Avalo Therapeutics's prepaid & other current changed year-over-year?
- Avalo Therapeutics's prepaid & other current increased by 264.7% year-over-year, from $1.83M to $6.69M.
- What is the long-term trend for Avalo Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Avalo Therapeutics's prepaid & other current has grown at a 21.0% compound annual growth rate (CAGR), from $2.66M to $6.91M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.